Unhinged

In Unhinged, psychiatrist Daniel Carlat chronicles his experiences practicing psychiatry and grapples with fundamental questions about the field. He details his journey from enthusiastic believer in psychopharmacology to someone who sees both the benefits and limitations of psychiatric medications. The book examines the relationship between psychiatrists and pharmaceutical companies, including how drug marketing influences prescription practices. Carlat describes the evolution of psychiatric diagnosis and treatment, incorporating historical context alongside personal observations from his clinical work. Through interviews with other practitioners and analysis of research, Carlat investigates core debates within psychiatry about the nature of mental illness and optimal treatment approaches. He explores the shift from talk therapy to medication management and its impact on patient care. The narrative raises essential questions about the current state of mental health care and the challenges of balancing scientific evidence with clinical judgment. It examines the intersection of medicine, marketing, and mental health while advocating for a more nuanced approach to psychiatric treatment.

Readers found this insider critique of psychiatric practices both illuminating and concerning. Mental health professionals praised Carlat's candid exposure of pharmaceutical marketing's influence on prescribing habits, while general readers valued the clear explanations of how psychiatric diagnoses and medications work. Positives: - Clear, accessible writing style for complex topics - Personal stories that illustrate systemic issues - Balanced perspective on medication's role - Practical suggestions for reform Negatives: - Some felt the personal narrative portions were self-serving - Wanted more concrete solutions - A few readers found it too basic for medical professionals Ratings: Goodreads: 3.9/5 (1,100+ ratings) Amazon: 4.3/5 (130+ ratings) Notable reader comment: "Carlat admirably admits his own participation in pharmaceutical marketing while highlighting its problems. His transparency adds credibility." - Goodreads reviewer Several medical students noted using it as supplemental reading for psychiatry rotations.

Anatomy of an Epidemic by Robert Whitaker This investigative work examines the rise of psychiatric medication use in America and questions the long-term effects of psychopharmaceutical treatments.

Manufacturing Depression by Gary Greenberg A practicing psychotherapist traces the transformation of depression into a medical condition and explores the relationship between pharmaceutical companies and psychiatric diagnosis.

Pharmageddon by David Healy The text documents the pharmaceutical industry's influence on medical research, prescription practices, and patient care through historical analysis and case studies.

Let Them Eat Prozac by David Healy A psychiatrist presents research and case histories that reveal the development, marketing, and impact of SSRI antidepressants on medical practice.

Our Daily Meds by Melody Petersen A former New York Times reporter examines the marketing practices of pharmaceutical companies and their impact on prescription drug consumption in America.

🔎 Daniel Carlat practiced as a psychiatrist for over 20 years before becoming a whistleblower about pharmaceutical marketing practices in psychiatry 💊 The author turned down $30,000 in speaking fees from pharmaceutical companies after realizing he had become what he calls a "drug company spokesman in disguise" 🏥 Carlat estimates that 80% of psychiatric medications are prescribed by primary care physicians rather than psychiatrists 📚 The book's publication in 2010 contributed to major changes in how pharmaceutical companies are allowed to interact with physicians 🎓 After writing "Unhinged," Carlat founded the Carlat Psychiatry Report, an influential medical education newsletter that accepts no pharmaceutical industry funding